New bladder cancer study could reduce need for repeated surgeries

NCT ID NCT06781879

Recruiting now Disease control Sponsor: Jakob Kristian Jakobsen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a drug treatment (chemoablation) can replace surgery for people with a common, recurring type of bladder cancer. About 272 adults with small, low-grade tumors that came back will either get the drug or standard surgery plus additional therapy. The goal is to see which approach better prevents the cancer from returning over two years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-invasive bladder urothelial carcinoma Non-Muscle Invasive Bladder Neoplasms Recurrence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-MUSCLE INVASIVE BLADDER CANCER

Contacts and locations

Locations

Aalborg University Hospital
NOT_YET_RECRUITING

Aalborg, Denmark
Aarhus University Hospital
RECRUITING

Aarhus N, 8200, Denmark
Haukeland University Hospital
NOT_YET_RECRUITING

Bergen, Norway
Herlev and Gentofte Hospital
RECRUITING

Herlev, Denmark
Landspítali University Hospital
NOT_YET_RECRUITING

Reykjavik, Iceland
NU Hospital Group
NOT_YET_RECRUITING

Uddevalla, Sweden
Vestfold Hospital Trust
NOT_YET_RECRUITING

Tønsberg, Norway
Zealand University Hospital, Roskilde
RECRUITING

Roskilde, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.